Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 3/20 | 0.38 |
| ▸ | MGLL | Q99685 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL486954 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL486952 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL9278970 | 0.98 | FAAH (0.39) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL120122 | 0.95 | ALDH1A1 (0.39) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL1771016 | 0.95 | ALDH1A1 (0.39) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL20853080 | 0.95 | ALDH1A1 (0.39) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL119856 | 0.95 | ALDH1A1 (0.39) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL28779856 | 0.94 | CA1 (0.37) | ALDH1A1TSHRFAAHMGLLCA1 | |
| SCHEMBL27771224 | 0.94 | FAAH (0.40) | ALDH1A1TSHRFAAHMGLLTRPV1 | |
| SCHEMBL2421576 | 0.89 | FAAH (0.34) | ALDH1A1TSHRFAAHMGLLCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1178031-B1 | PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH MANGANESE CATALYSTS OR THE LIKE | DAICEL CHEM (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-6548713-B2 | Efficiently producing a compound having an alkyl group or alkenyl group bonded at the alpha position of an electron attractive group, by catalytic radical addition reaction with compound of Group 5,6,7,8, or 9 | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-04-15 | — | — | US | disclosed |
| US-20020165416-A1 | Process for the preparation of organic compounds with manganese cataylsts or the like | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-11-07 | — | — | US | disclosed |
| EP-1178031-A1 | PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH MANGANESE CATALYSTS OR THE LIKE | Daicel Chemical Industries, Ltd. (JP) | 2002-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165416-A1 | Process for the preparation of organic compounds with manganese cataylsts or the like | SOD1, CAT, SOD3 | ALDH1A1 1198/4885TSHR 1204/4885FAAH 3968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.